Literature DB >> 28601954

Perioperative outcomes of robot-assisted laparoscopic partial cystectomy.

George C Bailey1, Igor Frank1, Matthew K Tollefson1, Matthew T Gettman1, John J Knoedler2.   

Abstract

Reports of surgical outcomes after robotic partial cystectomy are limited. The objective of this study is to review surgical outcomes after robotic partial cystectomy at a large tertiary referral center and compare outcomes with patients undergoing open partial cystectomy. Patients undergoing robotic partial cystectomy between 2003 and 2014 were identified. Patients were matched 2:1 based on gender, age, and Charlson Comorbidity Score with patients undergoing open partial cystectomy during the same time period. Patient charts were reviewed for surgical outcomes. Conditional logistic regression adjusted for matching was used to compare outcomes. At our institution, 11 patients underwent robotic partial cystectomy between 2003 and 2014. Median operative time was significantly longer in the robotic group, 214 (IQR 93, 230) minutes, than the open group, 93 (IQR 58, 143) minutes (p = 0.01). There was no difference in median estimated blood loss (p = 0.1). No patient required transfusion. There were no intraoperative complications. Median hospital stay was significantly shorter in the robotic partial cystectomy group, 1 (IQR 1, 2) day, than the open partial cystectomy group, 2 (IQR 2, 4) days (p = 0.01). Median duration of catheterization and complications within 30 days of surgery were not statistically different between the two groups. Median follow-up was 15.5 (IQR 8.6, 19.7) months for the robotic partial cystectomy group and 40.7 (IQR 6.5, 69.4) months for the open partial cystectomy group. Robotic partial cystectomy is safe, effective, and is associated with minimal morbidity when performed in properly selected patients for benign and malignant indications. When compared with open partial cystectomy, robotic partial cystectomy is associated with a longer operative time, but results in a shorter postoperative hospital stay.

Entities:  

Keywords:  Outcomes; Partial cystectomy; Robotics

Mesh:

Year:  2017        PMID: 28601954     DOI: 10.1007/s11701-017-0717-x

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  18 in total

Review 1.  Transurethral resection and partial cystectomy for invasive bladder cancer.

Authors:  M Laufer
Journal:  Semin Urol Oncol       Date:  2000-11

2.  Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance.

Authors:  Jonathan J Rhee; Sam Lebeau; Mark Smolkin; Dan Theodorescu
Journal:  BJU Int       Date:  2006-06-26       Impact factor: 5.588

3.  In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States.

Authors:  Max Kates; Michael A Gorin; Christopher M Deibert; Phillip M Pierorazio; Mark P Schoenberg; James M McKiernan; Trinity J Bivalacqua
Journal:  Urol Oncol       Date:  2013-11-13       Impact factor: 3.498

4.  Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Authors:  Wassim Kassouf; David Swanson; Ashish M Kamat; Dan Leibovici; Arlene Siefker-Radtke; Mark F Munsell; H Barton Grossman; Colin P N Dinney
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

5.  Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.

Authors:  Marco Roscigno; Cesare Cozzarini; Roberto Bertini; Vincenzo Scattoni; Massimo Freschi; Luigi Filippo Da Pozzo; Alberto Briganti; Andrea Gallina; Umberto Capitanio; Renzo Colombo; Guazzoni Giorgio; Francesco Montorsi; Patrizio Rigatti
Journal:  Eur Urol       Date:  2008-01-15       Impact factor: 20.096

6.  Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Authors:  Jeffrey M Holzbeierlein; Ernesto Lopez-Corona; Bernard H Bochner; Harry W Herr; S Machele Donat; Paul Russo; Guido Dalbagni; Pramod C Sogani
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.

Authors:  Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-07-22       Impact factor: 2.649

8.  Robot-assisted laparoscopic partial cystectomy and diverticulectomy: initial experience of four cases.

Authors:  Basir U Tareen; Patrick W Mufarrij; Guilherme Godoy; Michael D Stifelman
Journal:  J Endourol       Date:  2008-07       Impact factor: 2.942

9.  Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

Authors:  Phillip J Gray; Stacey A Fedewa; William U Shipley; Jason A Efstathiou; Chun Chieh Lin; Anthony L Zietman; Katherine S Virgo
Journal:  Eur Urol       Date:  2012-11-19       Impact factor: 20.096

10.  Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes.

Authors:  Raj S Pruthi; Eric M Wallen
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

View more
  3 in total

1.  Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease.

Authors:  James P Blackmur; Nadja Melquiot; Katherine E Robertson; Seamus Teahan
Journal:  BMJ Case Rep       Date:  2019-06-16

Review 2.  Partial cystectomy for muscle-invasive bladder cancer: a review of the literature.

Authors:  Taylor C Peak; Ashok Hemal
Journal:  Transl Androl Urol       Date:  2020-12

3.  Bladder diverticulectomy using a pre-peritoneal, trans-vesicle approach with the SP platform: A novel approach.

Authors:  Michael Tonzi; Mathew J Watson; Amar Singh
Journal:  Urol Case Rep       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.